Midatech Pharma Plc Shares float
What is the Shares float of Midatech Pharma Plc?
The Shares float of Midatech Pharma Plc is 85.470M 134.85%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with shares float similar to Midatech Pharma Plc
- Manali Petrochemicals has Shares float of 85.272M 49.58%
- Progressive Path has Shares float of 85.301M 8.22%
- The Real Brokerage Inc has Shares float of 85.341M 47.90%
- ITD Cementation India has Shares float of 85.408M 49.72%
- Asahi India Glass has Shares float of 85.419M 35.14%
- iTech Minerals Ltd has Shares float of 85.461M 72.13%
- Midatech Pharma Plc has Shares float of 85.470M 134.85%
- Atlantic Power has Shares float of 85.470M 95.27%
- Manali Petrochemicals has Shares float of 85.519M 49.72%
- Select Sands has Shares float of 85.545M 96.59%
- Greenlane Renewables has Shares float of 85.552M 64.60%
- Kleos Space S.A has Shares float of 85.562M 47.93%
- Doman Building Materials has Shares float of 85.563M 98.70%